Basil Systems operates the BasilIntel SaaS platform that ingests and structures regulatory, clinical, and post-market data into a single, searchable intelligence layer. Its BasilLink dataset indexes over 600 million records including regulatory submissions, drug labels, clinical trials, adverse event reports, guidances, recalls, inspections, and citations, continuously updated and structured. The platform provides full-text natural language querying, API connectivity, and enterprise-grade infrastructure designed to support millions of concurrent users, delivering answers to complex questions in seconds. Basil's customers include Johnson & Johnson, Medtronic, Baxter, four of the five largest global medical device companies, and it is in active trials with three top global pharmaceutical firms. Use cases span regulatory strategy, clinical planning, post-market surveillance, product development, supply chain optimization, risk mitigation, and real-world evidence analysis. Basil plans to expand data coverage, onboard additional enterprise clients, broaden support to adjacent life sciences players (manufacturers, suppliers, CROs, and regulatory agencies), and accelerate AI/ML deployment to automate complex workflows. Financially, the company announced a new $11.5 million funding round to deepen product capabilities and accelerate rollout across the pharma and medical device industry. Basil Systems delivers a commercial SaaS platform that leverages machine-learning across product, market, and regulatory data to provide analytics and insights for strategic product development, performance, supply chain management, and recall risk mitigation. The platform aims to reduce regulatory approval times and guide decisions for medical device and pharmaceutical companies. Basil has signed customer contracts with several Fortune 500 healthcare companies and industry service providers and supports law firms, consultancies, and regulators. The founding team previously built Co3 Systems (later Resilient Systems), which was acquired by IBM. Basil plans to aggressively expand its system and features to meet additional customer needs and to support purchasing groups, material and component suppliers, and distributors. The company released its commercial version publicly while announcing initial institutional funding.

Total raised

$13M

Funding rounds

2

Latest round

Equity

Latest activity

Apr 2025